Second-Quarter 2020 Business Performance Preannouncement

15 July, 2020

In light of the withdrawal of its annual objectives, bioMérieux, a world leader in the field of in vitro diagnostics, today announced preliminary quarterly information about its business activity ending June 30, 2020.

  • Organic growth of 15.7% at constant exchange rates and scope of consolidation over the first half of 2020:
    • €1,476 million in sales
    • Up 15.8% as reported
  • Sustained positive momentum of molecular biology product lines
  • As expected, adverse impact of the global health crisis on microbiology, immunoassay and industrial applications product lines
Download
Pioneering Diagnostics